Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4471 Acromegaly and small intestinal neuroendocrine tumours: Association or coincidence?

Introduction: Neuroendocrine tumours of the small intestine (SI-NETs), although rare, are the most prevalent primary neoplasms of this organ. Acromegaly is characterised by excessive secretion of growth hormone (GH), typically due to a pituitary adenoma, but in rare cases, it can result from ectopic secretion of GH-releasing hormone (GHRH) by non-pituitary tumours, particularly NETs of the lung or pancreas.

Conference:

Presenting Author: G. Martins R

Authors: Martins Fernandes A, Silva L, Serranito M, Elvas A, Santos J,

Keywords: neuroendocrine tumour, small intestinal neuroendocrine tumour, acromegaly,

#3572 Capecitabine and temozolomide in advanced neuroendocrine neoplasms – A single center experience

Introduction: Neuroendocrine neoplasms (NENs) are heterogeneous malignancies, with a great variability in clinical behaviour and prognosis. Capecitabine and temozolomide combination (CAPTEM) has shown positive results in these patients, with a good safety profile.

Conference:

Presenting Author:

Authors: Monteiro J, Caetano A, Pires M, Costa C, Elvas A,

Keywords: neuroendocrine neoplasm, neuroendocrine tumor, treatment, capecitabine, temozolomide, capecitabine and temozolomide, CAPTEM,

#3570 Metastatic middle ear neuroendocrine tumor treated with Somatostatin analogues and PRRT – A case report

Introduction: Neuroendocrine adenomas of the middle ear (NEAME) are rare tumors. They have mostly indolent biological behaviour, however, reports of an aggressive course and metastasis have been described.

Conference:

Presenting Author: Gomes Martins R

Authors: Elvas A, Magalhães J, Monteiro J, Barros J, Rei L,

Keywords: Neuroendocrine adenomas of the middle ear, somatostatin analogues, peptide receptor radionuclide therapy,

#3565 Grade 3 neuroendocrine neoplasms – Real life experience and prognostic biomarkers

Introduction: Grade 3 neuroendocrine neoplasms (G3 NEN) are a heterogeneous group, including well differentiated tumors (NET) and poorly differentiated carcinomas (NEC), whose identification can be challenging. Accessible prognostic tools are needed to individualize treatment. Data suggests neutrophil/lymphocyte ratios (NLR) and systemic inflammatory index (SII) have prognostic value in NEN.

Conference:

Presenting Author: Rebordão Pires M

Authors: Rebordão Pires M, Monteiro J, Amorim Costa C, Caetano A, Elvas A,

Keywords: Grade 3 neuroendocrine neoplasm, NEC, NET, Neutrophil to lymphocyte ratio, Systemic Inflammatory Index, Ki67, Prognostic biomarker,

#3564 Prevalence of other malignant cancers in patients with neuroendocrine neoplasms

Introduction: Neuroendocrine neoplasms (NNE) are a heterogeneous group, arising from different anatomical locations. Studies showed a higher prevalence of other malignancies associated with NNE when compared to other types of cancer.

Conference:

Presenting Author: Amorim Costa C

Authors: Amorim Costa C, Peixoto M, Rebordão Pires M, Cruz Monteiro J, Elvas A,

Keywords: Neuroendocrine neoplasm, solid malignancies, hematological malignancies, screening,